Anna Abrahamsson
- Oncology top 10%
- Surgery
- Cardiology and Cardiovascular Medicine top 10%
- Pathology and Forensic Medicine top 10%
- Molecular Biology
- Co-authors
- Ingemar BjörkhemCurt EinarssonEwa EllisMats JerkemanThomas AntonssonHenrik Toft SørensenJan-Erik NyströmErika Gyzander
- Topics
- Drug Transport and Resistance Mechanisms (7 papers)Pharmacogenetics and Drug Metabolism (5 papers)Liver Disease Diagnosis and Treatment (3 papers)
- Partner nations
- SwedenDenmarkUnited Kingdom
In The Last Decade
Anna Abrahamsson
19 papers receiving 792 citations
Peers
Comparison fields: 5 of 95
- Oncology 348
- Surgery 231
- Cardiology and Cardiovascular Medicine 157
- Pathology and Forensic Medicine 145
- Molecular Biology 132
Countries citing papers authored by Anna Abrahamsson
This map shows the geographic impact of Anna Abrahamsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Abrahamsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Abrahamsson more than expected).
Fields of papers citing papers by Anna Abrahamsson
This network shows the impact of papers produced by Anna Abrahamsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Abrahamsson. The network helps show where Anna Abrahamsson may publish in the future.
Co-authorship network of co-authors of Anna Abrahamsson
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Abrahamsson. A scholar is included among the top collaborators of Anna Abrahamsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Abrahamsson. Anna Abrahamsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 13 | |
| 3 | 18 | |
| 4 | 45 | |
| 5 | Variance Adaptive Quantization and Adaptive Offset Selection in High Efficiency Video Coding | 1 |
| 6 | 11 | |
| 7 | 96 | |
| 8 | 2 | |
| 9 | 20 | |
| 10 | 43 | |
| 11 | 16 | |
| 12 | 17 | |
| 13 | 46 | |
| 14 | 80 | |
| 15 | 14 | |
| 16 | 236 | |
| 17 | 29 | |
| 18 | 74 | |
| 19 | 41 |
About Anna Abrahamsson
Anna Abrahamsson is a scholar working on Pharmacology, Oncology and Toxicology, having authored 19 papers that have together received 816 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Internal Medicine (118 citations), Pharmacology (122 citations) and Oncology (348 citations). Anna Abrahamsson has collaborated with scholars based in Sweden, Denmark and United Kingdom. Frequent co-authors include Ingemar Björkhem, Curt Einarsson, Ewa Ellis, Mats Jerkeman, Thomas Antonsson, Henrik Toft Sørensen, Jan-Erik Nyström, Erika Gyzander, Ulf Bredberg and Kurt‐Jürgen Hoffmann. Their work appears in journals such as Blood, Hepatology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.